BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20819909)

  • 1. An integrated genomic analysis of aryl hydrocarbon receptor-mediated inhibition of B-cell differentiation.
    De Abrew KN; Kaminski NE; Thomas RS
    Toxicol Sci; 2010 Dec; 118(2):454-69. PubMed ID: 20819909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of genome-wide computation DRE search, AhR ChIP-chip and gene expression analyses of TCDD-elicited responses in the mouse liver.
    Dere E; Lo R; Celius T; Matthews J; Zacharewski TR
    BMC Genomics; 2011 Jul; 12():365. PubMed ID: 21762485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
    Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
    Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
    Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
    Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.
    Phadnis-Moghe AS; Crawford RB; Kaminski NE
    Toxicol Sci; 2015 Mar; 144(1):39-50. PubMed ID: 25543051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
    Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
    J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    De Abrew KN; Phadnis AS; Crawford RB; Kaminski NE; Thomas RS
    Toxicol Appl Pharmacol; 2011 Apr; 252(2):150-8. PubMed ID: 21296099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The AhR and NF-κB/Rel Proteins Mediate the Inhibitory Effect of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin on the 3' Immunoglobulin Heavy Chain Regulatory Region.
    Salisbury RL; Sulentic CE
    Toxicol Sci; 2015 Dec; 148(2):443-59. PubMed ID: 26377645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
    Sulentic CE; Holsapple MP; Kaminski NE
    J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene regulation by the human and mouse aryl hydrocarbon receptor.
    Flaveny CA; Murray IA; Perdew GH
    Toxicol Sci; 2010 Apr; 114(2):217-25. PubMed ID: 20044593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental exposure to 2,3,7,8 tetrachlorodibenzo-p-dioxin attenuates capacity of hematopoietic stem cells to undergo lymphocyte differentiation.
    Ahrenhoerster LS; Tate ER; Lakatos PA; Wang X; Laiosa MD
    Toxicol Appl Pharmacol; 2014 Jun; 277(2):172-82. PubMed ID: 24709672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of TCDD-induced AhR-mediated gene expression in human, mouse and rat primary B cells.
    Kovalova N; Nault R; Crawford R; Zacharewski TR; Kaminski NE
    Toxicol Appl Pharmacol; 2017 Feb; 316():95-106. PubMed ID: 27913140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution genome-wide mapping of AHR and ARNT binding sites by ChIP-Seq.
    Lo R; Matthews J
    Toxicol Sci; 2012 Dec; 130(2):349-61. PubMed ID: 22903824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of aryl hydrocarbon receptor binding targets in mouse hepatic tissue treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Lo R; Celius T; Forgacs AL; Dere E; MacPherson L; Harper P; Zacharewski T; Matthews J
    Toxicol Appl Pharmacol; 2011 Nov; 257(1):38-47. PubMed ID: 21889950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-Wide ChIPseq Analysis of AhR, COUP-TF, and HNF4 Enrichment in TCDD-Treated Mouse Liver.
    Cholico GN; Nault R; Zacharewski TR
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of the aryl hydrocarbon receptor-responsive genes and modulation of the immunoglobulin M response by 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary human B cells.
    Lu H; Crawford RB; Suarez-Martinez JE; Kaplan BL; Kaminski NE
    Toxicol Sci; 2010 Nov; 118(1):86-97. PubMed ID: 20702590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver.
    Sato S; Shirakawa H; Tomita S; Ohsaki Y; Haketa K; Tooi O; Santo N; Tohkin M; Furukawa Y; Gonzalez FJ; Komai M
    Toxicol Appl Pharmacol; 2008 May; 229(1):10-9. PubMed ID: 18295293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.